Latest filing published 20 Sept 2018 for Principia Biopharma Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +45.4%Entry US$15.56 · Close at T+365 US$22.63
- -70.6%Entry US$654.15 · Close at T+365 US$192.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sofinnova Venture Partners VIII, L.P.: trading record in brief
This profile gathers the share dealings of Sofinnova Venture Partners VIII, L.P. across 4 companies, led by Ocugen, Inc., Principia Biopharma Inc. and Synlogic, Inc. The record holds 17 filings, for trades running from 8 December 2014 to 18 September 2018.
Market trades split into 4 purchases (€17.7M) and 1 sale (€8,965). Purchases outweigh sales by €17.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. In 2018 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €4.2M and half below.
Most recently, on 20 September 2018, the filings show a transaction in Principia Biopharma Inc. The last insider purchase was made public on 20 September 2018, 2,972 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Sofinnova Venture Partners VIII, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 625,482 sharesCommon StockSEC:0001209191-18-051838:0
- 521,235 sharesCommon StockSEC:0001209191-18-051838:1
- 453,954 sharesCommon StockSEC:0001209191-18-051838:2
- 167,537 sharesCommon StockSEC:0001209191-18-051838:3
- ▲
Same trade as the filing by New Leaf Ventures II, L.P., counted once
5M USD31SEC270,000 shares@ US$17.00100.0% of flowCommon StockSEC:0001209191-18-051838:4Canonical exit: 17 Dec 2018 (T+90) - 1,880,390 sharesCommon StockSEC:0001209191-15-075196:0
- 409,090 shares@ US$11.00Common StockSEC:0001209191-15-075196:1Canonical exit: 11 Jan 2016 (T+90)
- 1,244,269 sharesCommon StockSEC:0001144204-15-058275:0
- 583,559 sharesCommon StockSEC:0001144204-15-058275:1
- 289,841 shares0Common StockSEC:0001144204-15-058275:2
- 857,142 shares@ US$7.00Common StockSEC:0001144204-15-058275:3Canonical exit: 4 Jan 2016 (T+90)
- 960,345 sharesCommon StockSEC:0001144204-14-073112:0
- 611,738 sharesCommon StockSEC:0001144204-14-073112:1
- 14,569 shares@ US$0.76Common StockSEC:0001144204-14-073112:2
- 1,002 shares@ US$11.00Common StockSEC:0001144204-14-073112:3
- 500,198 shares@ US$11.00Common StockSEC:0001144204-14-073112:4Canonical exit: 8 Mar 2015 (T+90)
- 8,808 sharesCommon StockSEC:0001144204-14-073112:5
17 of 16 declarations
